ORGANOGENESIS HOLDINGS INC. - CLASS A
5.4100
03-March-25 16:45:00
15 minutes delayed
Stocks
-0.8000
-12.88%
Today's range
5.3350 - 6.7100
ISIN
N/A
Source
NASDAQ
-
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
27 Feb 2025 16:05:01 By Nasdaq GlobeNewswire
-
27 Jan 2025 07:30:00 By Nasdaq GlobeNewswire
-
Organogenesis Expands Manufacturing Capacity to Support Future Growth
22 Nov 2024 16:05:00 By Nasdaq GlobeNewswire
-
Organogenesis Commends Final LCDs
15 Nov 2024 09:25:44 By Nasdaq GlobeNewswire
-
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
12 Nov 2024 16:05:01 By Nasdaq GlobeNewswire
-
12 Nov 2024 16:01:00 By Nasdaq GlobeNewswire
-
11 Nov 2024 17:05:00 By Nasdaq GlobeNewswire
-
16 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
01 Oct 2024 16:05:00 By Nasdaq GlobeNewswire
-
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
04 Sep 2024 16:05:00 By Nasdaq GlobeNewswire
-
Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results
08 Aug 2024 16:05:01 By Nasdaq GlobeNewswire
-
Organogenesis Shares ReNu® Program Update
08 Aug 2024 16:04:00 By Nasdaq GlobeNewswire
-
15 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
06 Jun 2024 16:05:00 By Nasdaq GlobeNewswire
-
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
09 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
02 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
16 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
03 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
29 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
12 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >